CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $12,000 | -14.3% | 5,000 | 0.0% | 0.00% | – |
Q4 2017 | $14,000 | -92.0% | 5,000 | -89.8% | 0.00% | – |
Q1 2017 | $176,000 | -5.4% | 48,835 | 0.0% | 0.00% | – |
Q4 2016 | $186,000 | +6100.0% | 48,835 | +6411.3% | 0.00% | – |
Q3 2016 | $3,000 | -98.4% | 750 | -98.3% | 0.00% | – |
Q2 2016 | $188,000 | +4600.0% | 42,885 | +4083.9% | 0.00% | – |
Q1 2016 | $4,000 | -76.5% | 1,025 | -7.1% | 0.00% | – |
Q4 2015 | $17,000 | +54.5% | 1,103 | +7.6% | 0.00% | – |
Q3 2015 | $11,000 | -99.1% | 1,025 | -98.0% | 0.00% | -100.0% |
Q2 2015 | $1,287,000 | +197.2% | 51,042 | +228.9% | 0.00% | +100.0% |
Q1 2015 | $433,000 | -0.7% | 15,519 | -35.0% | 0.00% | – |
Q4 2014 | $436,000 | +41.1% | 23,869 | +0.3% | 0.00% | – |
Q3 2014 | $309,000 | -43.6% | 23,800 | -29.1% | 0.00% | -100.0% |
Q2 2014 | $548,000 | – | 33,570 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |